2013 - Page 2 of 5 - EpiVax, Inc. - Informatics and Immunology

The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix

The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix

by epivax3 | Oct 22, 2016

Hum Vaccin Immunother. 2013 Apr 12;9(7). PubMed PMID 23584251

Report from the field: Overview of the Sixth Annual Vaccine Renaissance Conference

by epivax3 | Oct 22, 2016

Hum Vaccin Immunother. 2013 Jul;9(7):1555-7. doi: 10.4161/hv.24833. Epub 2013 May 31.

Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design

Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design

by epivax3 | Oct 22, 2016

Hum Vaccin Immunother. Volume 9, Issue 5 May 2013:950–956.

Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease

Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease

by epivax3 | Oct 22, 2016

Virus Res. 2013 Jul 22. doi:pii: S0168-1702(13)00231-1. 10.1016/j.virusres.2013.07.009.

Making Vaccines “On Demand”: A Potential Solution for Emerging Pathogens and Biodefense?

by epivax3 | Oct 22, 2016

Human Vaccines and Immunotherapy. Sep 2013.

« Older Entries

Next Entries »